Keeping in view the cumulative information from earlier research in the field of GH and cancer [14,76] as well as our current findings, combined GHR antagonism appears to offer a method of making radiotherapy, chemotherapy, as well as specific targeted therapies more efficacious not only in melanoma, but also in other solid tumors which overexpress the GHR. Here, GHR is linked to melanoma.